Effect of Acanthopanax senticosus on Lipoprotein Lipase in 3T3-L1 Adipocytes

Phytotherapy Research

Volumn 18, Issue 2, 2004, Pages 160-163

  Yang, Jeong Yeh ^a   Lee, Kang Seop ^b   Kim, Myung Kon ^c   Moon, Seong Keun ^a   Kang, Mi Kyung ^a   Park, Byung Hyun ^a   Kim, Jong Suk ^a   Park, Jin Woo ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Panax Bio Institute   (South Korea)

^c Iksan National College   (South Korea)

Author keywords

Acanthopanax senticosus; Adipocyte; Hypertriglyceridaemia; Lipoprotein lipase

Indexed keywords

ELEUTHEROCOCCUS SENTICOSUS EXTRACT; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; WATER;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CATALYSIS; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXTRACTION; HYPERTRIGLYCERIDEMIA; NONHUMAN; RAT; TRANSCRIPTION REGULATION;

3T3 CELLS; ACANTHOPANAX; ADIPOCYTES; ANIMALS; ANTILIPEMIC AGENTS; DNA PRIMERS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ACANTHOPANAX; ELEUTHEROCOCCUS SENTICOSUS;

EID: 1642264939     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1413     Document Type: Article

References (22)

1. Bensadoun A. 1991. Lipoprotein lipase. Annu Rev Nutr 11: 217-237.
2. Enerback S, Gimble JM. 1993. Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1169: 107-125.
3. Feingold KR, Marshall M, Gulli R, Moser AH, Grunfeld C. 1994. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb 14: 1866-1872.
4. Gaffney BT, Hugel HM, Rich PA. 2001. The effects of Eleutherococcus senticosus and Panax ginseng on steroidal hormone indices of stress and lymphocyte subset numbers in endurance athletes. Life Sci 70: 431-442.
5. Glatthaar-Saalmuller B, Sacher F, Esperester A. 2001. Antiviral activity of an extract derived from roots of Eleutherococcus senticosus. Antiviral Res 50: 223-228.
6. Hara T, Cameron-Smith D, Cooney GJ, Kusunoki M, Tsutsumi K, Storlien LH. 1998. The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructosefed rats. Metabolism 47: 149-153.
7. Hibasami H, Fujikawa T, Takeda H, et al. 2000. Induction of apoptosis by Acanthopanax senticosus HARMS and its component, sesamin in human stomach cancer KATO III cells. Oncol Rep 7: 1213-1216.
8. Lanza-Jacoby S, Phetteplace H, Sedkova N, Knee G. 1998. Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia. Shock 9: 46-51.
9. Lin CC, Huang PC. 2000. Antioxidant and hepatoprotective effects of Acathopanax senticosus. Phytother Res 14: 489-494.
10. Mahley RW, Bersot TP. 2001. Drug therapy for hypercholesterolemia and dyslipidemia. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Hardman JG, Limberd LE, Gilman AG (eds). McGraw-Hill: New York; 971-1002.
11. Malloy MJ, Kane JP. 2001. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 47: 111-136.
12. Mead JR, Ramji DP. 2002. The pivotal role of lipoprotein lipase in atherosclerosis. Cardiovasc Res 55: 261-269.
13. Nilsson-Ehle P, Schotz MC. 1976. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17: 536-541.
14. Ohara M, Tsutsumi K, Ohsawa N. 1998. Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator. Metabolism 47: 101-105.
15. Park JW, Lee SY, Yang JY, et al. 1997. Effect of carbonyl cyanide m-chlorophenylhydrazone (CCCP) on the dimerization of lipoprotein lipase. Biochim Biophys Acta 1344: 132-138.
16. Rapp RJ. 2002. Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 10: 163-172.
17. Steinmann GG, Esperester A, Joller P. 2001. Immunopharmacological in vitro effects of Eleutherococcus senticosus extracts. Arzneimittelforschung 51: 76-83.
18. Sui DY, Lu ZZ, Li SH, Cai Y. 1994. Hypoglycemic effect of saponin isolated from leaves of Acanthopanax senticosus (Rupr. et Maxin.) Harms. Zhongguo Zhong Yao Za Zhi 19: 683-685.
19. Szolomicki J, Samochowiec L, Wojcicki J, Drozdzik M, Szolomicki S. 2000. The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man. Phytother Res 14: 30-35.
20. Tsutsumi K, Inoue Y, Shima A, Iwasaki K, Kawamura M, Murase T. 1993. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest 92: 411-417.
21. Wagner H, Norr H, Winterhoff H. 1994. Plant adaptogens. Phytomedicine 1: 63-76.
22. Yin W, Tsutsumi K, Yuan Z, Yang B. 2002. Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits. Arzneimittelforschung 52: 610-614.